(6R)-5,10-Methylenetetrahydrofolate; Modufolin; UNII-Z8R4A37V9Q; 31690-11-6; Methylenetetrahydrofolic acid, L-(+)-; (6R)-5,10-methylenetetrahydrofolic acid; CHEBI:1989; Z8R4A37V9Q; L-(+)-methylenetetrahydrofolic acid; 31690-11-6 (free); 5,10-methylene-THF; 5,10-methylenetetrahydrofolate; 3432-99-3; (4-((R)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl)-L-glutamic acid; N-({4-[(6ar)-3-Amino-1-Oxo-1,2,5,6,6a,7-Hexahydroimidazo[1,5-F]pteridin-8(9h)-Yl]phenyl}carbonyl)-L-Glutamic Acid; N-{4-[(6aR)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl}-L-glutamic acid; Arfolitixorin [USAN]; 6R-MTHF; Arfolitixorin (USAN/INN); SCHEMBL186747; CHEMBL1234270; DTXSID60185584; ISO-901; BCP09003; ZINC4228243; (6R)-5,10-MTHF; WHO 10689; DB12676; 5,10-methylene-(6r)-tetrahydrofolic acid; 5,10-methylene,5,6,7,8-tetrahydrofolate; D11447; Q26995704; (6r,s)-5,10-methylene-5,6,7,8-tetrahydrofolic acid; [6R]-5,10-methylenetetrahydrofolate ([6R]-5,10- MTHF); UNII-0SXY5ET48B component QYNUQALWYRSVHF-OLZOCXBDSA-N; (S)-2-(4-((R)-3-Amino-1-oxo-5,6,6a,7-tetrahydroimidazo[1,5-f]pteridin-8(1H,4H,9H)-yl)benzamido)pentanedioic acid; N-({4-[(6aR)-3-amino-1-oxo-1,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]phenyl}carbonyl)-L-glutamic acid